Review by two specialists remains in place for patients initiating valproate under 55 years of age but the Commission on Human Medicines…

Healthcare professionals should be aware of the potential risk of pulmonary aspiration in patients using GLP-1 or dual GIP/GLP-1 receptor agonists who…

A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices. 

A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.

The ninth annual #MedSafetyWeek social media campaign is taking place 4 to 10 November 2024.

A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.

Healthcare professionals are reminded to inform patients about the common and serious side effects associated with glucagon-like peptide-1 receptor agonists (GLP-1RAs).

We ask healthcare professionals to support new guidance for users of diabetes management equipment, their families, care givers and representatives.

A safety review has been conducted by the MHRA following a Yellow Card report concerning a patient who was taking bromocriptine. The…

A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.